Skip to content
Business Company News, Medical Health Aged Care

Professor Peter van Wijngaarden to become next Director and CEO of The Florey

The Florey 2 mins read

The Florey Board appoints new Director and CEO  

After an extensive global search, Professor Peter van Wijngaarden has been named as the next Director and CEO of The Florey Institute of Neuroscience and Mental Health. 

Board Chair Mr Martin Adams said Professor van Wijngaarden is an outstanding leader and an experienced clinician researcher who will take The Florey’s work to the world stage. 

“On behalf of the Board, I warmly welcome Peter to The Florey. As the largest brain research centre in the Southern Hemisphere, The Florey is home to remarkably talented people committed to advancing neuroscience and mental health research. Peter is exceptionally well-placed to take The Florey’s impact to the next level.” 

Professor van Wijngaarden said he was looking forward to taking up his new role next month. 

“I am honoured to be joining The Florey as its new Director and excited to be working with scientists who are leading the world in making fundamental discoveries in neuroscience and improving diagnostics and treatments for an impressive range of mental health and brain-related conditions,” Professor van Wijngaarden said.  

“The Florey has an incredible reputation and I look forward to building on that impressive legacy,” he said. 

Mr Adams thanked retiring Director Professor Trevor Kilpatrick for his leadership and commitment to the organisation.  

"Trevor has done an outstanding job leading The Florey through a period of important structural changes which have positioned us to continue to make significant scientific breakthroughs with our partners. I’m confident that Peter will build upon these efforts.”  

Professor Kilpatrick said he was proud to have served The Florey as its sixth Director. 

“I’m delighted that Professor van Wijngaarden has accepted this appointment,” Professor Kilpatrick said.  

“I have known Peter since his return from Cambridge where he undertook research in regenerative neuroscience with my long-term friend and colleague Professor Robin Franklin. 

“Since then, Peter has had a stellar career as a clinician scientist, administrator and entrepreneur. He is ideally placed to lead The Florey in the next phase of its journey as a world-leading neuroscience and mental health-oriented research institute.” 

Peter is Professor of Ophthalmology at the University of Melbourne and has served as Deputy Director at the Centre for Eye Research Australia (CERA). 

His research interests include retinal imaging, artificial intelligence, multiple sclerosis and Alzheimer’s disease. 

 


Key Facts:
  • Professor Peter van Wijngaarden has been selected to lead The Florey from 1 August 2024 

  • Professor van Wijngaarden is currently Deputy Director of the Centre for Eye Research Australia 


About us:

The Florey is Australia’s leading brain research institute with a focus on improving the lives of people with neurological and psychiatric conditions. The Florey’s research missions are centred around dementia, epilepsy, mental health and developing ways to protect and repair the brain. These missions are strengthened by The Florey’s expertise in neurotherapeutics, neuroimaging, synaptic biology and systems neuroscience. With 600 researchers, The Florey is the largest research centre of its kind in the southern hemisphere.

Find out more about us on our website: www.florey.edu.au


Contact details:

Kathryn Powley, Media and Communications Manager

kathryn.powley@florey.edu.au | 0456 666 271

Media

More from this category

  • Medical Health Aged Care
  • 22/10/2024
  • 12:48
Monash University

Monash Expert: Preparing for this years’ thunderstorm asthma season

The highest risk period for thunderstorm asthma is here, if you suffer from asthma or hay fever, it is important to be prepared. Thunderstorm asthma occurs when people develop serious asthma symptoms over a short period of time caused by high amounts of pollen and a certain type of thunderstorm. You can check the Victorian Government’s epidemic thunderstorm asthma risk forecast here: health.vic.gov.au A Monash expert is available to talk about tips on how to cope with and prepare for this years’ thunderstorm asthma season. Professor Mark Hew, Head of Allergy, Asthma and Clinical Immunology, Alfred Hospital, and Adjunct Clinical…

  • Business Company News
  • 22/10/2024
  • 11:00
Chapter One Advisors

Canaccord Genuity Upgrades Little Green Pharma to Speculative Buy, Increases Price Target to $0.21

Little Green Pharma (ASX: LGP) has received a strong vote of confidence from Canaccord Genuity, which has upgraded its rating toSpeculative BuyfromHold (see research…

  • Contains:
  • Business Company News, Oil Mining Resources
  • 22/10/2024
  • 10:51
Jane Morgan Management

American Rare Earths Receives First Reimbursement of A$450,000 from Wyoming State Grant to Advance Cowboy State Mine

Sydney, Australia – 22 October 2024 | American Rare Earths Limited (ASX:ARR | OTCQX:ARRNF | ADR:AMRRY) (“American Rare Earths” or “the Company”) is pleased to announce that it has received its first reimbursement of over A$450,000 (US$304,000) from the Wyoming Energy Authority (WEA) grant. This significant milestone marks ongoing progress in the development of the Company’s flagship Cowboy State Mine at the Halleck Creek Rare Earths Project in the state of Wyoming, USA. Highlights: A$450,000 Reimbursement: The first reimbursement from the WEA grant has been received following the approval of the Company’s A$10.7 million (US$7.1 million) grant proposal in June…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.